Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2026-02-11 @ 2:46 PM
Study NCT ID:
NCT02910050
Status:
UNKNOWN
Last Update Posted:
2017-12-22
First Post:
2016-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer
Sponsor:
Xu fei
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
None
Primary Completion Date:
2018-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-12
Completion Date Type:
ESTIMATED
First Submit Date:
2016-09-06
First Submit QC Date:
None
Study First Post Date:
2016-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-21
Last Update Post Date:
2017-12-22
Last Update Post Date Type:
ACTUAL